Literature DB >> 29201735

Interstitial Pneumonitis Related to Pegylated Interferon Alfa-2a Treatment in a Patient with Chronic Hepatitis C.

Erhan Alkan1, Mete Akin2, Haydar Adanir3, Yasar Tuna4.   

Abstract

Alkan E, Akin M, Adanir H, Tuna Y. Interstitial Pneumonitis Related to Pegylated Interferon Alfa-2a Treatment in a Patient with Chronic Hepatitis C. Euroasian J Hepato-Gastroenterol 2016;6(1):91-92.

Entities:  

Keywords:  Chronic hepatitis C; Interstitial pneumonitis; Pegylated interferon; Therapy.

Year:  2016        PMID： 29201735      PMCID： PMC5578569          DOI： 10.5005/jp-journals-10018-1176

Source DB:  PubMed          Journal:  Euroasian J Hepatogastroenterol        ISSN： 2231-5047


  7 in total

Review 1.  Side effects of therapy of hepatitis C and their management.

Authors:  Michael W Fried
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

2.  Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis.

Authors:  T Ishizaki; F Sasaki; S Ameshima; K Shiozaki; H Takahashi; Y Abe; S Ito; M Kuriyama; T Nakai; M Kitagawa
Journal:  Eur Respir J       Date:  1996-12       Impact factor: 16.671

3.  Side effects of high-dose interferon therapy for chronic hepatitis C.

Authors:  T Okanoue; S Sakamoto; Y Itoh; M Minami; K Yasui; M Sakamoto; K Nishioji; T Katagishi; Y Nakagawa; H Tada; Y Sawa; M Mizuno; K Kagawa; K Kashima
Journal:  J Hepatol       Date:  1996-09       Impact factor: 25.083

Review 4.  Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature.

Authors:  John Midturi; Miguel Sierra-Hoffman; Douglas Hurley; Richard Winn; Robert Beissner; John Carpenter
Journal:  Clin Infect Dis       Date:  2004-11-08       Impact factor: 9.079

5.  Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report.

Authors:  Ozlen Atug; Hakan Akin; Yesim Ozen Alahdab; Berrin Ceyhan; Nurdan Tozun; Osman Ozdogan
Journal:  Cases J       Date:  2009-03-10

6.  Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C.

Authors:  K Shiva Kumar; Mark W Russo; Alain C Borczuk; Melissa Brown; Stephen P Esposito; Steven J Lobritto; Ira M Jacobson; Robert S Brown
Journal:  Am J Gastroenterol       Date:  2002-09       Impact factor: 10.864

Review 7.  Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature.

Authors:  Serena Slavenburg; Yvonne F Heijdra; Joost P H Drenth
Journal:  Dig Dis Sci       Date:  2009-04-28       Impact factor: 3.199
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.